New pill targets Leukemia's weak spot in frail patients
Disease control
Not yet recruiting
This study is testing an oral medication called ziftomenib for adults with a specific type of acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The drug works by blocking a specific pathway (the menin pathway) that these leukemia cells n…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC